25021-471Level 3
fulvestrant (fulvestrant)
**Product type:** Human Prescription Drug
**Active ingredient:** FULVESTRANT
**Strength:** 50 mg/mL
**Dosage form:** Injection, Solution
**Route:** Intramuscular
**Labeler:** Sagent Pharmaceuticals
**Marketing category:** ANDA (ANDA211422)
**Pharmacologic class:** Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]
GET
/api/v1/systems/ndc_fda/nodes/25021-471Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.